Controlled release from multilayer silk biomaterial coatings to modulate vascular cell responses

Biomaterials

Volumn 29, Issue 7, 2008, Pages 894-903

  Wang, Xianyan ^a   Zhang, Xiaohui ^a   Castellot, John ^b   Herman, Ira ^b   Iafrati, Mark ^c   Kaplan, David L ^a,b  

^a Tufts University   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

Clopidogrel; Fibroin; Heparin; Paclitaxel; Silk; Stent

Indexed keywords

BIOASSAY; BIOMARKERS; CELL ADHESION; DRUG DELIVERY; ENDOTHELIAL CELLS; MULTILAYERS; MUSCLE; ORGANIC COATINGS; PLATELETS; SILK;

CLOPIDOGREL; DRUG CARRIERS; PACLITAXEL;

PROTEINS;

BIOMATERIAL; CLOPIDOGREL; DRUG CARRIER; HEPARIN; PACLITAXEL; SILK FIBROIN;

ANIMAL EXPERIMENT; AORTA; ARTICLE; BLOOD VESSEL; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; DRUG MECHANISM; DRUG SYNTHESIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MATERIAL COATING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RESTENOSIS; THROMBOCYTE ADHESION;

ANIMALS; AORTA; BIOCOMPATIBLE MATERIALS; BOMBYX; CELL ADHESION; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FIBROINS; HUMANS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, SCANNING; PHENOTYPE; SILK; STENTS; SWINE;

COATINGS; FIBROIN; HEPARIN; MULTILAYERS; PROTEINS; SILK;

SUS;

EID: 37249003847     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2007.10.055     Document Type: Article

References (36)

1. Serruys P., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331 (1994) 489-495
2. Fischman D.L., Leon M.B., Baim D.S., Schatz R.A., Savage M.P., Penn I., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 331 (1994) 496-501
3. Kuntz R.E., Gibson C.M., Nobuyoshi M., and Baim D.S. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol 21 (1993) 15-25
4. Mintz G.S., Popma J.J., Pichard A.D., Kent K.M., Satler L.F., Wong L.F., et al. Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study. Circulation 94 (1996) 35-43
5. Fattori R., and Piva T. Drug-eluting stents in vascular intervention. Lancet 361 (2003) 247-249
6. Babapulle M.N., and Eisenberg M.J. Circulation 106 21 (2002) 2734-2740
7. Welt F.G., and Rogers C. Inflammation and restenosis in the stent era. Arterioscler Thromb Vasc Biol 22 11 (2002) 1769-1776
8. Ong A.T.L., and Serruys P.W. Technology insight: an overview of research in drug-eluting stents. Nat Clin Prac Cardiovasc Med 2 (2005) 647-658
9. Lev E.I., Assali A.R., Teplisky I., Rechavia E., Hasdai D., Sela O., et al. Comparison of outcomes up to six months of heparin-coated with noncoated stents after percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 93 6 (2004) 741-743
10. van der Giessen W.J., Lincoff A.M., Schwartz R.S., van Beusekom H.M., Serruys P.W., Holmes Jr. D.R., et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 94 7 (1996) 1690-1697
11. Fischell T.A. Polymer coatings for stents can we judge a stent by its cover?. Circulation 94 (1996) 1494-1495
12. Friess W. Collagen-biomaterial for drug delivery. Eur J Pharm Biopharm 45 2 (1998) 113-136
13. Chen M.C., Liang H.F., Chiu Y.L., Chang Y., Wei H.J., and Sung H.W. A novel drug-eluting stent spray-coated with multi-layers of collagen and sirolimus. J Controlled Release 108 1&2 (2005) 178-189
14. Thierry B., Winnik F.M., Merhi Y., Silver J., and Tabrizian M. Bioactive coatings of endovascular stents based on polyelectrolyte multilayers. Biomacromolecules 4 (2003) 1564-1571
15. Panilaitis B., Altman G.H., Chen J., Jin H.J., Karageorgiou V., and Kaplan D.L. Macrophage responses to silk. Biomaterials 24 18 (2003) 3079-3085
16. Meinel L., Karageorgiou V., Hofmann S., Fajardo R., Snyder B., Li C., et al. Engineering bone-like tissue in vitro using human bone marrow stem cells and silk scaffolds. J Biomed Mater Res A 71 1 (2004) 25-34
17. Nazarov R., Jin H.J., and Kaplan D.L. Porous 3D scaffolds from regenerated silk fibroin. Biomacromolecules 5 (2004) 718-726
18. Kim U.J., Park J., Li C., Jin H.J., Valluzzi R., and Kaplan D.L. Structure and properties of silk hydrogels. Biomacromolecules 5 (2004) 786-792
19. Jin H.J., Park J., Karageorgiou V., Kim U.J., Valluzzi R., Cebe P., et al. Water-stable silk films with reduced β-sheet content. Adv Funct Mater 15 8 (2005) 1241-1247
20. Horan R.L., Antle K., Collette A.L., Wang Y., Huang J., Moreau J.E., et al. In vitro degradation of silk fibroin. Biomaterials 26 (2005) 3385-3393
21. Wang X.Y., Hu X., Daley A., Rabotyagova O., Cebe P., and Kaplan D.L. Nanolayer biomaterial coatings of silk fibroin for controlled release. J Controlled Release 121 3 (2007) 190-199
22. Hofmann S., Foo C.W., Rossetti C., Textor M., Merkle H.P., Kaplan D.L., et al. Silk fibroin as an organic polymer for controlled drug delivery. J Controlled Release 111 (2006) 219-227
23. Bayraktar O., Malay O., Ozgarip Y., and Batgun A. Silk fibroinas a novel coating material for controlled release of theophylline. Eur J Pharm Biopharm 60 (2005) 373-381
24. Kim U.J., Park J.H., Kim H.J., Wada M., and Kaplan D.L. Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials 26 15 (2005) 2775-2785
25. Lake A.C., and Castellot J.J. CCN5 modulates the antiproliferative effect of heparin and regulates cell motility in vascular smooth muscle cells. Cell Commun Signal 1 5 (2003) 1-13
26. Kim D.W., Ahn H.Y., Kim Y.G., Piao H., Youn T.J., Cho M.C., et al. Local delivery of paclitaxel as an approach to the prevention of stenosis following angioplasty of the rat carotid artery. Korean J Cardiovasc Dis 1 1 (2000) 119-126
27. Tartivel R., Reynaud E., Grasset F., Sangleboeuf J.C., and Rouxel R. Superscratch-resistant glass by means of a transparent nanostructured inorganic coating. J Non-Cryst Solids 353 (2007) 108-110
28. Houérou V.L., Sangleboeuf J.C., Dériano S., Rouxel T., and Duisit G. Surface damage of soda-lime-silica glasses: indentation scratch behavior. J Non-Cryst Solids 316 1 (2003) 54-63
29. Jones F., Ryffel H., Oberg E., McCauley C., and Heald R. Machinery's handbook. Toolbox ed (2004), Industrial Press, Inc.
30. Gieck K., and Gieck R. Engineering formulas. 7th ed (1997), McGraw-Hill, New York
31. Hermann A., Weber A., and Schrör K. Clopidogrel inhibits platelet adhesion and platelet-dependent mitogenesis in vascular smooth muscle cells. Thromb Res 105 (2002) 173-175
32. Klein-Soyer C., Cazenave J.P., Herbert J.M., and Maffrand J.P. SR 25989 inhibits healing of a mechanical wound of confluent human saphenous vein endothelial cells which is modulated by standard heparin and growth factors. J Cell Physiol 160 2 (1994) 316-322
33. Bauters C., Passart F., Lablanche J.M., McFadden E.P., Hamon M., and Bertrand M.F. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis. Eur Heart J 17 (1996) 1671-1677
34. Aronson D., Bloomgarden Z., and Rayfield E.J. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol 27 3 (1996) 528-535
35. Hardhammar P.A., van Beusekom H.M., Emanuelsson H.U., Hofma S.H., Albertsson P.A., Verdouw P.D., et al. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 93 3 (1996) 423-430
36. Serruys P.W., van Hout B., and Bonnier H. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet 352 9129 (1998) 673-681